Filing metadata

Accession number
0000950170-23-056944
Form type
Form 4
Filer
Ambrx Biopharma, Inc.
CIK
CIK 1990550
Filed
Oct 31, 2023
Reporting period
Oct 27, 2023
Description
Insider transaction

Explore SEC Filings Hub